rubeosis

参考

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

Ranibizumab as adjuvant in the treatment of rubeosis iridis and neovascular glaucoma-results from a prospective interventional case series.

Lüke J, Nassar K, Lüke M, Grisanti S.SourceDepartment of Ophthalmology, University of Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany, julia.lueke@uk-sh.de.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie.Graefes Arch Clin Exp Ophthalmol.2013 Jul 28. [Epub ahead of print]
BACKGROUND: To evaluate the capability of adjuvant intraocular ranibizumab (Lucentis®) injections in the treatment of rubeosis and intraocular pressure in patients with rubeosis and neovascular glaucoma.METHODS: Ten eyes with rubeosis (R) and ten eyes with neovascular glaucoma (NVG) received Lucent
PMID 23893090

Retrospective analysis of the success and safety of Gold Micro Shunt Implantation in glaucoma.

Hueber A, Roters S, Jordan JF, Konen W.AbstractBACKGROUND: To evaluate the success rate and adverse effects of Gold Micro Shunt Plus (GMS+) implantation into the supraciliary space.
BMC ophthalmology.BMC Ophthalmol.2013 Jul 18;13(1):35. [Epub ahead of print]
BACKGROUND: To evaluate the success rate and adverse effects of Gold Micro Shunt Plus (GMS+) implantation into the supraciliary space.METHODS: This retrospective study included 31 eyes of 31 patients diagnosed with severe glaucoma and uncontrolled intraocular pressure (IOP) with implantation of a GM
PMID 23865804

[Choroidal melanoma treated by protontherapy: Anatomical and functional results at Strasbourg University Medical Center.]

Saleh M, Zhang J, Benichou C, Hermsdorff C, Bourcier T, Sauer A, Speeg-Schatz C, Gaucher D.SourceService d'ophtalmologie, nouvel hôpital civil, CHU de Strasbourg, 1, place de l'Hôpital, BP 426, 67091 Strasbourg cedex, France; Service d'ophtalmologie, université de Franche-Comté, CHU Jean-Minjoz de Besançon, 3, boulevard Flemming, 25000 Besançon, France. Electronic address: msaleh@chu-besancon.fr.
Journal francais d'ophtalmologie.J Fr Ophtalmol.2013 Jun 25. pii: S0181-5512(13)00093-4. doi: 10.1016/j.jfo.2012.08.008. [Epub ahead of print]
PURPOSE: To report anatomical and functional results of choroidal melanoma treated by protontherapy between 2001 and 2011 and to compare these with data reported in the literature.METHODS: The present study is a retrospective review of the charts of patients presenting with choroidal melanoma, manag
PMID 23809200